NEW YORK (AP) _ Intercept Pharmaceuticals Inc. (ICPT) on Wednesday reported a loss of $90.3 million in its first quarter.
On a per-share basis, the New York-based company said it had a loss of $3.03.
The results fell short of Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.57 per share.
The drugmaker posted revenue of $52.3 million in the period, which beat Street forecasts. Eight analysts surveyed by Zacks expected $51.7 million.
Intercept shares have decreased 16% since the beginning of the year. The stock has climbed 21% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICPT at https://www.zacks.com/ap/ICPT